Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study-Reference-Cited by-同舟云学术

Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study

Published:2019-05 Issue: Volume:63 Page:56-61
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Andersson Charlotte^ORCID,Hansen Peter Wæde,Steffensen Ida E.,Andreasen Charlotte,Weeke Peter E.,Køber Lars,Gislason Gunnar H.,Torp-Pedersen Christian^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference45 articles.

1. Global Health epidemiology reference G. Global and regional estimates of COPD prevalence: systematic review and meta-analysis;Adeloye;J Glob Health,2015

2. Unrecognised ventricular dysfunction in COPD;Macchia;Eur Respir J,2012

3. Epidemiology of chronic obstructive pulmonary disease: a literature review;Rycroft;Int J Chron Obstruct Pulmon Dis,2012

4. Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease;Wells;Circ Cardiovasc Imaging,2015

5. Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension;Hilde;J Am Coll Cardiol,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment;European Journal of Internal Medicine;2024-08

2. Analysis of C-reactive protein and lactoferrin levels in patients with myocardial infarction with chronic obstructive pulmonary disease depending on presence of complications;Medical alphabet;2023-10-20

3. Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group;Pulmonary Circulation;2023-10

4. Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients;Biomedicines;2023-07-12

5. Protective effect of crocin on chronic heart failure and its mechanism of action;Tropical Journal of Pharmaceutical Research;2023-02-18